0 comments
12th Jan 11
adminAt the annual Life Sciences Alley meeting held in Minneapolis (December 8, 2010), presenters dissected the economic benefit of new medical innovations to our global society. It was an eye-opening discussion trained on the theoretical best methods to capture new innovations’ relative and absolute economic value.
Presenters from most sectors of our industry – manufacturers, healthcare providers and government – were pressing on the core theme — the need for a centralized system to act as a dynamic repository for capturing the economic value of therapies and diagnostic modalities, as well as their procedures, throughout the life-course of patient’s care to assess the true economic value to our healthcare system.
In the U.S. they call this “Comparative Effectiveness Research” (“CER”); in the EU they call it “Health Technology Effectiveness” (“HTE”). No matter what it is called, this grassroots movement is slowly evolving us to a new breed of clinical trial protocols capturing not only safety and efficacy/effectiveness but also economic value and comparing that value with that of the “gold standards” of care at any point in time.
What was not presented was what agency or group that would take the responsibility to fund and create the central data repository. There was a large minority agreeing that in the U.S. it will need to be a centralized service, similar to ClinicalTrials.gov…and it would likely cost billions of dollars to develop, commercialize and manage.
But where does that leave the developer and manufacturers of our new medical innovations? I am convinced that manufacturers need to act now and on a smaller scale. Each company will need to establish its own data management system (DMS) that is easy to use and compatible with the newly evolving central system, allowing as seamless uploads to this planned national central repository as possible.
Your comments?
Next week…likely solutions for practical DMS.
Stay alert, be intelligent -
Victoria Hunsicker Sanko – Senior Editor
Subscribe to “Economic Issues in U.S. Healthcare” Breaking News”
Jordan Zornes – Editor & Senior Analyst
